| Pathway ID | Description | value | Numbers of DEmRNAs |
| hsa05206 | MicroRNAs in cancer | 6.39-05 | CCND1, E2F2, MMP16, VIM, HMGA2 | hsa04660 | T cell receptor signaling pathway | 4.60-04 | ITK, CTLA4, CARD11 | hsa04060 | Cytokine-cytokine receptor interaction | 5.30-04 | FASLG, IL20RB, CXCL10, CCL20 | hsa04110 | Cell cycle | 7.37-04 | CCND1, CDC6, E2F2 | hsa04152 | AMPK signaling pathway | 7.54-04 | SCD, CCND1, CD36 | hsa00514 | Other types of O-glycan biosynthesis | 9.62-04 | GXYLT2, ST6GAL1 | hsa05161 | Hepatitis B | 1.17-03 | FASLG, CCND1, E2F2 | hsa05219 | Bladder cancer | 1.63-03 | CCND1, E2F2 | hsa05202 | Transcriptional misregulation in cancer | 2.10-03 | SPI1, SIX4, HMGA2 | hsa05200 | Pathways in cancer | 2.31-03 | SPI1, FASLG, CCND1, E2F2 |
|
|